S Jaishankar pointed to India’s strong record in non-proliferation of dual-use goods, the globally recognised Vaccine Maitri initiative during the COVID-19 pandemic, and the country’s proposals for a National Implementation Framework that covers identification of high-risk biological agents, oversight of dual-use research.